Enlitic Locks in US$1.5M Penn Medicine Deal to Migrate 71M Patient Files
Key Takeaways
Enlitic Inc (ASX: ENL) secures a US$1.5 million Enlitic Penn Medicine Data Migration contract to transfer 71 million legacy clinical files, marking the company's second project with one of America's most prestigious academic health systems.
- Enlitic has signed a US$1.5 million contract with Penn Medicine Doylestown Health to migrate over 71 million legacy clinical files into a modernised archive structure via its wholly-owned subsidiary Laitek.
- This is the second data migration project between Enlitic and Penn Medicine, demonstrating repeat business and an established commercial relationship with a leading US academic health system.
- The project is scheduled to commence in Q2 2026 with expected completion within calendar year 2026, providing near-term revenue visibility.
- Enlitic's CEO has signalled intent to expand the relationship beyond data migration by pursuing implementation of additional Enlitic AI solutions within the Penn Medicine network.
Enlitic secures US$1.5 million Penn Medicine contract to migrate 71 million clinical files
Enlitic Inc (ASX: ENL) has signed a US$1.5 million data migration contract with Penn Medicine Doylestown Health, part of Penn Medicine, University of Pennsylvania Health System. The Enlitic Penn Medicine Data Migration project will involve transferring over 71 million legacy clinical files into a modernised archive structure.
Penn Medicine Doylestown Health is a regional healthcare provider in Pennsylvania that became part of the Penn Medicine network in 2025. Penn Medicine, University of Pennsylvania Health System is described as one of the world’s leading academic health systems in the US. The system centres around Doylestown Hospital, a well-established community hospital serving Bucks County and surrounding regions.
This marks the second project of its kind between Enlitic and Penn Medicine, demonstrating an ongoing commercial relationship with one of America’s most prestigious academic medical centres. The project is scheduled to commence in Q2 2026, with expected completion later in calendar year 2026.
When big ASX news breaks, our subscribers know first
What is clinical data migration and why healthcare providers need it
Clinical data migration refers to the process of transferring patient records and medical imaging files from older, legacy systems into modern digital platforms. Hospitals accumulate vast archives of patient records over decades, stored in systems that become difficult to maintain or access as technology evolves.
The migration process involves transforming, indexing, and validating historical data so it remains clinically accessible in modern electronic medical record environments. This ensures that healthcare providers can continue to access complete patient histories whilst modernising their IT infrastructure.
Healthcare providers globally face regulatory and operational pressure to modernise legacy archives whilst preserving data integrity, accessibility, and clinical utility. This creates recurring demand for specialised data migration services as hospitals upgrade their systems whilst maintaining compliance with strict healthcare data standards.
Contract details and Laitek’s role
Under the agreement, Laitek, Enlitic’s 100%-owned medical imaging data migration and integration company, will execute the project. Laitek will migrate over 71 million legacy clinical files from the hospital’s existing electronic medical record archive environment into a modernised archive structure within Enlitic’s platform.
The company stated it will utilise a bespoke solution created specifically for Penn Medicine, described as proprietary to ENL. The project encompasses data transformation, indexing, and validation to support continued clinical access to historical records.
| Contract Element | Detail |
|---|---|
| Contract Value | US$1.5 million |
| Files to Migrate | 71 million legacy clinical files |
| Solution Provider | Laitek (100%-owned by Enlitic) |
| Project Start | Q2 2026 |
| Expected Completion | Calendar year 2026 |
The proprietary nature of the solution and the scale of files involved indicates Laitek’s technical capabilities for enterprise-level healthcare deployments. The company described the projects as highly specialised, positioning Laitek’s expertise as a differentiator in the medical data migration market.
The next major ASX story will hit our subscribers first
Penn Medicine relationship and expansion opportunity
This contract represents the second project of its kind with Penn Medicine, indicating an established partnership between the organisations. Penn Medicine Doylestown Health’s integration into the Penn Medicine network in 2025 appears to have created the opportunity for this additional engagement.
Enlitic CEO Michael Sistenich
“We are pleased to have an opportunity to work with Penn Medicine again in this capacity and further highlight Laitek’s capabilities to manage complex clinical data migration and transformation projects. Beyond the immediate contract value, the Company intends to pursue the implementation of additional Enlitic solutions with Penn Medicine. We hope to utilise this initial contract as an opportunity to meaningfully expand our relationship with another leading US health system.”
Management stated the company intends to pursue implementation of additional Enlitic solutions with Penn Medicine beyond the current data migration scope. This approach positions the migration contract as a potential entry point to broader platform adoption rather than a standalone project.
The announcement described the initiative as demonstrating considerable validation of the company’s service offering and reiterating Enlitic’s position as a long-term, established partner to leading organisations in the US healthcare sector.
Enlitic’s positioning in US healthcare
Enlitic describes itself as a software company that uses artificial intelligence to develop products that manage medical imaging data in radiology, including MRI, CT scans, X-ray and ultrasound images. The company licences these products to healthcare providers.
Enlitic’s value proposition centres on several core capabilities:
- AI-powered medical imaging data management
- Standardisation and integration of clinical data across systems
- Legacy archive modernisation capabilities delivered through Laitek
- Foundation for real-world evidence platform development to improve clinical workflows
The company’s products aim to standardise, protect, integrate, and analyse data to create the foundation of a real-world evidence platform that can improve clinical workflows, increase efficiencies, and expand capacity.
Each partnership with major US health systems strengthens Enlitic’s reference base and credibility for winning additional enterprise contracts in the American healthcare market. The repeat business from Penn Medicine positions the company as a trusted partner capable of handling complex, mission-critical data projects for leading academic medical centres.
Want the Next Healthcare Tech Winner in Your Inbox?
Join 20,000+ investors getting FREE ASX healthcare and tech news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to start receiving breaking announcements the moment they hit the market.